Free Trial

Tandem Diabetes Care (TNDM) Earnings Date, Estimates & Call Transcripts

Tandem Diabetes Care logo
$17.03 -0.03 (-0.18%)
As of 04/14/2025 04:00 PM Eastern

Tandem Diabetes Care Earnings Summary

Upcoming Q4
Earnings Date
Apr. 30Before Market OpensEstimated
Consensus EPS
(Nov. 6)
-$0.43
Actual EPS
(Nov. 6)
-$0.35 Beat By $0.08
Actual Revenue
(Nov. 6)
$243.97M

Tandem Diabetes Care posted Q3 2024 earnings on November 6, 2024, reporting an EPS of -$0.35, which beat analysts' consensus estimates of -$0.43 by $0.08. Quarterly revenue rose 31.4% year-over-year to $243.97 million, above the consensus estimate of $224.14 million. With a trailing EPS of -$1.46, Tandem Diabetes Care's earnings are expected to grow next year, from ($1.68) to ($1.20) per share.

Q3 2024 Earnings Resources

TNDM Upcoming Earnings

Tandem Diabetes Care's Q1 2025 earnings is scheduled for Wednesday, April 30, 2025, with a conference call scheduled at 4:30 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Get Tandem Diabetes Care Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Tandem Diabetes Care and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

TNDM Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

TNDM Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.
Remove Ads

Tandem Diabetes Care Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20252-$0.56-$0.42-$0.49
Q2 20252-$0.37-$0.26-$0.32
Q3 20251-$0.15-$0.15-$0.15
Q4 20251-$0.09-$0.09-$0.09
FY 20256($1.17)($0.92)($1.05)
Remove Ads

Tandem Diabetes Care Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
4/30/2025
(Estimated)
-------
11/6/2024Q3 2024-$0.43-$0.35+$0.08-$0.37$224.14M$243.97M
8/1/2024Q2 2024-$0.54-$0.47+$0.07-$0.47$205.63M$221.90M
5/2/2024Q1 2024-$0.80-$0.63+$0.17-$0.61$173.06M$191.67M
2/21/2024Q4 2023-$0.23-$0.27 -$0.04-$0.08$204.86M$196.80M
11/1/2023Q3 2023-$0.35-$0.38 -$0.03-$0.25$193.33M$185.62M
8/3/2023Q2 2023-$0.54-$0.30+$0.24-$0.05$201.62M$195.92M
5/3/2023Q1 2023-$0.56-$0.63 -$0.07$0.66$171.59M$169.38M

Tandem Diabetes Care Earnings - Frequently Asked Questions

Tandem Diabetes Care has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, April 30th, 2025 based off last year's report dates. Learn more on TNDM's earnings history.

Tandem Diabetes Care updated its first quarter 2025 earnings guidance on Wednesday, February, 26th. The company issued revenue guidance of $219.0 million-$224.0 million, compared to the consensus revenue estimate of $220.7 million.

In the previous quarter, Tandem Diabetes Care (NASDAQ:TNDM) reported ($0.35) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.43) by $0.08. Learn more on analysts' earnings estimate vs. TNDM's actual earnings.

The conference call for Tandem Diabetes Care's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Tandem Diabetes Care's latest earnings report can be read online.
Read Transcript

Tandem Diabetes Care's earnings report can be found in their filing with the SEC.
View SEC filing

Tandem Diabetes Care (NASDAQ:TNDM) has a recorded annual revenue of $940.20 million.

Tandem Diabetes Care (NASDAQ:TNDM) has a recorded net income of -$222.61 million. TNDM has generated -$1.46 earnings per share over the last four quarters.

Tandem Diabetes Care's earnings are expected to grow from ($1.68) per share to ($1.20) per share in the next year.

More Earnings Resources from MarketBeat

Remove Ads


This page (NASDAQ:TNDM) was last updated on 4/15/2025 by MarketBeat.com Staff
From Our Partners